Temporal Course of Pregnancy-Associated Plasma Protein-A in Angioplasty-Treated ST-Elevation Myocardial Infarction Patients and Potential Significance of Concomitant Heparin Administration

American Journal of Cardiology

Volumn 103, Issue 1, 2009, Pages 29-35

  Terkelsen, Christian J ^a   Oxvig, Claus ^b   Nørgaard, Bjarne L ^a   Glerup, Simon ^b   Poulsen, Tina S ^c   Lassen, Jens F ^a   Møller, Holger J ^a   Thuesen, Leif ^a   Falk, Erling ^a   Nielsen, Torsten T ^a   Andersen, Henning R ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD163 ANTIGEN; HEPARIN; PREGNANCY ASSOCIATED PLASMA PROTEIN A; TROPONIN T;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOPLASTY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CLEARANCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; ANTICOAGULANTS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOCARDIAL INFARCTION; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 58149464875     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.08.027     Document Type: Article

References (26)

1. Bayes-Genis A., Conover C.A., Overgaard M.T., Bailey K.R., Christiansen M., Holmes Jr. D.R., Virmani R., Oxvig C., and Schwartz R.S. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345 (2001) 1022-1029
2. Apple F.S., Wu A.H., Mair J., Ravkilde J., Panteghini M., Tate J., Pagani F., Christensen R.H., Mockel M., Danne O., Jaffe A.S., and Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51 (2005) 810-824
3. Aristoteli L.P., Moller H.J., Bailey B., Moestrup S.K., and Kritharides L. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis. Atherosclerosis 184 (2006) 342-347
4. Terkelsen C.J., Norgaard B.L., Lassen J.F., Poulsen S.H., Gerdes J.C., Sloth E., Gøtzsche L.B., Rømer F.K., Thuesen L., Nielsen T.T., and Andersen H.R. Potential significance of spontaneous and interventional ST-changes in patients transferred for primary percutaneous coronary intervention: observations from the ST-Monitoring in Acute Myocardial Infarction study (the MONAMI study). Eur Heart J 27 (2006) 267-275
5. van Hof A.W.J., Liem A., de Boer M.-J., Zijlstra F., and Zwolle Myocardial Infarction Study Group. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 350 (1997) 615-619
6. Overgaard M.T., Haaning J., Boldt H.B., Olsen I.M., Laursen L.S., Christiansen M., Gleich G.J., Sottrup-Jensen L., Conover C.A., and Oxvig C. Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275 (2000) 31128-31133
7. Thygesen K., Alpert J.S., White H.D., and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 28 (2007) 2525-2538
8. Nielsen L.S., Svanegaard J., Klitgaard N.A., and Egeblad H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnoea. Eur J Heart Fail 6 (2004) 63-70
9. Moller H.J., Hald K., and Moestrup S.K. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest 62 (2002) 293-299
10. Moller H.J., Peterslund N.A., Graversen J.H., and Moestrup S.K. Identification of the hemoglobin scavenger receptor/CD163 as a natural soluble protein in plasma. Blood 99 (2002) 378-380
11. Kim W., Sogaard P., Egeblad H., Andersen N., and Kristensen B. Three-dimensional echocardiography with tissue harmonic imaging shows excellent reproducibility in assessment of left ventricular volumes. J Am Soc Echocardiogr 14 (2001) 612-617
12. Kim W., Sogaard P., Kristensen B., and Egeblad H. Measurement of left ventricular volumes by 3-dimensional echocardiography with tissue harmonic imaging: a comparison with magnetic resonance imaging. J Am Soc Echocardiogr 14 (2001) 169-179
13. TIMI Study Group. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med 312 (1985) 932-936
14. Gibson C.M., Cannon C.P., Daley W.L., Dodge Jr. J.T., Alexander B., Marble S.J., McCabe C.H., Raymond L., Fortin T., Poole W.K., and Braunwald E. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93 (1996) 879-888
15. Hof A.W.J., Liem A., Suryapranata H., Hoorntje J.C.A., de Boer M.J., and Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Circulation 97 (1998) 2302-2306
16. Poulsen T.S., Kristensen S.R., Korsholm L., Haghfelt T., Jorgensen B., Licht P.B., and Mickley H. Variation and importance of aspirin resistance in patients with known cardiovascular disease. Thromb Res 120 (2007) 477-484
17. Oxvig C., Sand O., Kristensen T., Gleich G.J., and Sottrup-Jensen L. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268 (1993) 12243-12246
18. Cosin-Sales J., Christiansen M., Kaminski P., Oxvig C., Overgaard M.T., Cole D., Holt D.W., and Kaski J.C. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 109 (2004) 1724-1728
19. Heeschen C., Dimmeler S., Hamm C.W., Fichtlscherer S., Simoons M.L., and Zeiher A.M. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45 (2005) 229-237
20. Brugger-Andersen T., Hetland O., Ponitz V., Grundt H., and Nilsen D.W. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and d-dimer in acute myocardial infarction. Thromb Res 119 (2007) 415-421
21. Lund J., Qin Q.P., Ilva T., Nikus K., Eskola M., Porela P., Kokkala S., Pulkki K., Pettersson K., and Voipio-Pulkki L.M. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 38 (2006) 221-228
22. Laursen L.S., Overgaard M.T., Weyer K., Boldt H.B., Ebbesen P., Christiansen M., Sottrup-Jensen L., Giudice L.C., and Oxvig C. Cell surface targeting of pregnancy-associated plasma protein A proteolytic activity. Reversible adhesion is mediated by two neighboring short consensus repeats. J Biol Chem 277 (2002) 47225-47234
23. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M., Ferrer J., and Vargas M. Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarction. Clin Biochem 38 (2005) 180-182
24. Iversen K.K., Teisner A.S., Teisner B., Kliem A., Thanning P., Grande P., and Clemmensen P. Pregnancy associated plasma protein A, a novel, quick, and sensitive marker in ST-elevation myocardial infarction. Am J Cardiol 101 (2008) 1389-1394
25. Spencer K. The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system. Ann Clin Biochem 40 (2003) 166-168
26. Qin Q.P., Christiansen M., and Pettersson K. Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem 48 (2002) 473-483